P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)B.C. Cho, D.-W. Kim, J.-Y. Han et al.|Journal of Thoracic Oncology|2022Cited by 7